AnalystsRobert LeBoyerRobert LeBoyer's Stock Forecasts
AnalystsRobert LeBoyer
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4033 out of 4566 analysts
Average Return
-13.31%
Win Rate
17%2 out of 12
Risk vs Reward
Poor
Good
Robert LeBoyer Analyst Color
Get additional color on Robert LeBoyer's coverage of popular stocks
Robert LeBoyer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Unicycive Therapeutics IncUNCY | 1 | Buy | $6.00 | +482.52% | Initiates Coverage On | 2 months ago |
Cadrenal Therapeutics IncCVKD | 1 | Buy | $4.00 | +830.23% | Initiates Coverage On | 4 months ago |
Eledon Pharmaceuticals IncELDN | 1 | Buy | $10.00 | +385.44% | Initiates Coverage On | 7 months ago |
Geovax Labs IncGOVX | 1 | Buy | $90.00 | +6,238.03% | Initiates Coverage On | a year ago |
Maia Biotechnology IncMAIA | 1 | Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
Ayala Pharmaceuticals IncAYLA | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Tonix Pharmaceuticals Holding CorpTNXP | 1 | Buy | $19.20 | N/A | Initiates Coverage On | 2 years ago |
Axcella Health IncAXLA | 1 | Buy | $150.00 | N/A | Initiates Coverage On | 3 years ago |
Plus Therapeutics IncPSTV | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 3 years ago |
Anavex Life Sciences CorpAVXL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Cns Pharmaceuticals IncCNSP | 1 | Strong Buy | $330.00 | N/A | Initiates Coverage On | 4 years ago |
Vtv Therapeutics IncVTVT | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Neurotrope IncNTRP1 | 2 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.